Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
affitope pd03a (1 trial)
Neurodegenerative Diseases (Phase 1)
Parkinson Disease (Phase 1)
Trials (1 total)
Trial APIs (1 total)